Hyperinsulinemia: Effect on cardiac mass/function, angiotensin II receptor expression, and insulin signaling pathways

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 291, Issue 2, 2006, Pages

  Samuelsson, Anne Maj ^a   Bollano, Entela ^a   Mobini, Reza ^a   Larsson, Britt Mari ^a   Omerovic, Elmir ^a   Fu, Michael ^a   Waagstein, Finn ^a   Holmäng, Agneta ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Hypertrophy; Mitogen activated protein kinase; Phosphatidylinositol 3 kinase; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; METOPROLOL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P85; PROTEIN SUBUNIT; S6 KINASE; SERINE; THREONINE; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL GROWTH; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE FIBROSIS; HEART OUTPUT; HEART STROKE VOLUME; HEART VENTRICLE HYPERTROPHY; HEART VOLUME; HEART WEIGHT; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; TIBIA; VASCULARIZATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; BODY WEIGHT; ELECTROCARDIOGRAPHY; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEART; HEMODYNAMIC PROCESSES; HYPERINSULINISM; IMMUNOHISTOCHEMISTRY; INSULIN; MITOGEN-ACTIVATED PROTEIN KINASES; ORGAN SIZE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VENTRICULAR FUNCTION, LEFT;

EID: 33746789770     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00974.2005     Document Type: Article

References (63)

1. Alessi DR and Cohen P. Mechanism of activation and function of protein kinase B. Curr Opin Genet Dev 8: 55-62, 1998.
2. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB, and Cohen P. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr Biol 7: 261-269, 1997.
3. Alessi DR, Kozlowski MT, Weng QP, Morrice N, and Avruch J. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr Biol 8: 69-81, 1998.
4. Alloatti G, Montrucchio G, Lembo G, and Hirsch E. Phosphoinositide 3-kinase gamma: kinase-dependent and -independent activities in cardiovascular function and disease. Biochem Soc Trans 32: 383-386, 2004.
5. Ameen C, Linden D, Larsson BM, Mode A, Holmang A, and Oscarsson J. Effects of gender and GH secretory pattern on sterol regulatory element-binding protein-1c and its target genes in rat liver. Am J Physiol Endocrinol Metab 287: E1039-E1048, 2004.
6. Andreozzi F, Laratta E, Sciacqua A, Perticone F, and Sesti G. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells. Circ Res 94: 1211-1218, 2004.
7. Avanza AC Jr, El Aouar LM, and Mill JG. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan. Arq Bras Cardiol 74: 103-117, 2000.
8. Banskota NK, Taub R, Zellner K, and King GL. Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells. Mol Endocrinol 3: 1183-1190, 1989.
9. Berg CE, Lavan BE, and Rondinone CM. Rapamycin partially prevents insulin resistance induced by chronic insulin treatment. Biochem Biophys Res Commun 293: 1021-1027, 2002.
10. Bia MJ, Tyler KA, and DeFronzo RA. Regulation of extrarenal potassium homeostasis by adrenal hormones in rats. Am J Physiol Renal Fluid Electrolyte Physiol 242: F641-F644, 1982.
11. Bursztyn M, Ben-Ishay D, Mekler J, and Raz I. Chronic exogenous hyperinsulinaemia without sugar supplementation: acute salt-sensitive hypertension without changes in resting blood pressure. J Hypertens 11: 703-707, 1993.
12. Carvalheira JB, Calegari VC, Zecchin HG, Nadruz W Jr, Guimaraes RB, Ribeiro EB, Franchini KG, Velloso LA, and Saad MJ. The cross-talk between angiotensin and insulin differentially affects phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-mediated signaling in rat heart: implications for insulin resistance. Endocrinology 144: 5604-5614, 2003.
13. Conus NM, Hemmings BA, and Pearson RB. Differential regulation by calcium reveals distinct signaling requirements for the activation of Akt and p70S6k. J Biol Chem 273: 4776-4782, 1998.
14. Cross DA, Alessi DR, Cohen P, Andjelkovich M, and Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789, 1995.
15. Devereux RB and Roman MJ. Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences. Hypertens Res 22: 1-9, 1999.
16. Du J, Sperling LS, Marrero MB, Phillips L, and Delafontaine P. G-protein and tyrosine kinase receptor cross-talk in rat aortic smooth muscle cells: thrombin- and angiotensin II-induced tyrosine phosphorylation of insulin receptor substrate-1 and insulin-like growth factor 1 receptor. Biochem Biophys Res Commun 218: 934-939, 1996.
17. Eguchi S, Iwasaki H, Ueno H, Frank GD, Motley ED, Eguchi K, Marumo F, Hirata Y, and Inagami T. Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt. J Biol Chem 274: 36843-36851, 1999.
18. Elbaz N, Bedecs K, Masson M, Sutren M, Strosberg AD, and Nahmias C. Functional trans-inactivation of insulin receptor kinase by growth-inhibitory angiotensin II AT2 receptor. Mol Endocrinol 14: 795-804, 2000.
19. Elton TS and Martin MM. Alternative splicing: a novel mechanism to fine-tune the expression and function of the human AT1 receptor. Trends Endocrinol Metab 14: 66-71, 2003.
20. Folli F, Kahn CR, Hansen H, Bouchie JL, and Feener EP. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J Clin Invest 100: 2158-2169, 1997.
21. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, and Tsichlis PN. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727-736, 1995.
22. Glennon PE, Kaddoura S, Sale EM, Sale GJ, Fuller SJ, and Sugden PH. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ Res 78: 954-961, 1996.
23. Gual P, Le Marchand-Brustel Y, and Tanti JF. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87: 99-109, 2005.
24. Holmang A, Brzezinska Z, and Bjorntorp P. Effects of hyperinsulinemia on muscle fiber composition and capillarization in rats. Diabetes 42: 1073-1081, 1993.
25. Holmang A, Jennische E, and Bjorntorp P. The effects of long-term hyperinsulinaemia on insulin sensitivity in rats. Acta Physiol Scand 153: 67-73, 1995.
26. Holmang A, Jennische E, and Bjorntorp P. Rapid formation of capillary endothelial cells in rat skeletal muscle after exposure to insulin. Diabetologia 39: 206-211, 1996.
27. Ilercil A, Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK, Fabsitz RR, and Howard BV. Associations of insulin levels with left ventricular structure and function in American Indians: the strong heart study. Diabetes 51: 1543-1547, 2002.
28. Jefferies HB, Reinhard C, Kozma SC, and Thomas G. Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. Proc Natl Acad Sci USA 91: 4441-4445, 1994.
29. Kintscher U and Unger T. Angiotensin II receptor expression: from maturation to pathogenesis. Am J Physiol Regul Integr Comp Physiol 285: R26-R27, 2003.
30. Kohn AD, Summers SA, Birnbaum MJ, and Roth RA. Expression of a constitutively active Akt Ser/Thrkinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271: 31372-31378, 1996.
31. Kuemmerle JF. IGF-I elicits growth of human intestinal smooth muscle cells by activation of PI3K, PDK-1, and p70S6 kinase. Am J Physiol Gastrointest Liver Physiol 284: G411-G422, 2003.
32. Levy D, Garrison RJ, Savage DD, Kannel WB, and Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322: 1561-1566, 1990.
33. Lijnen PJ and Petrov VV. Role of intracardiac renin-angiotensin- aldosterone system in extracellular matrix remodeling. Methods Find Exp Clin Pharmacol 25: 541-564, 2003.
34. Long W, Barrett EJ, Wei L, and Liu Z. Adrenalectomy enhances the insulin sensitivity of muscle protein synthesis. Am J Physiol Endocrinol Metab 284: E102-E109, 2003.
35. Lorell BH. Role of angiotensin AT1, and AT2 receptors in cardiac hypertrophy and disease. Am J Cardiol 83: 48H-52H, 1999.
36. Manning BD. Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J Cell Biol 167: 399-403, 2004.
37. Nickenig G, Michaelsen F, Muller C, Vogel T, Strehlow K, and Bohm M. Posttranscriptional regulation of the AT1 receptor mRNA. Identification of the mRNA binding motif and functional characterization. FASEB J 15: 1490-1492, 2001.
38. Nickenig G, Roling J, Strehlow K, Schnabel P, and Bohm M. Insulin induces upregulation of vascular AT1 receptor gene expression by post-transcriptional mechanisms. Circulation 98: 2453-2460, 1998.
39. Nikolaidis LA, Sturzu A, Stolarski C, Elahi D, Shen YT, and Shannon RP. The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy. Cardiovasc Res 61: 297-306, 2004.
40. Nilsson C, Larsson BM, Jennische E, Eriksson E, Bjorntorp P, York DA, and Holmang A. Maternal endotoxemia results in obesity and insulin resistance in adult male offspring. Endocrinology 142: 2622-2630, 2001.
41. Oka-Akagi T, Fujimori A, Shibasaki M, Matsuda-Satoh Y, Inagaki O, and Yanagisawa I. Effects of angiotensin II type 1 receptor antagonist, YM358, on cardiac hypertrophy and dysfunction after myocardial infarction in rats. Biol Pharm Bull 25: 857-860, 2002.
42. Omerovic E, Bollano E, Soussi B, and Waagstein F. Selective beta1-blockade attenuates post-infarct remodelling without improvement in myocardial energy metabolism and function in rats with heart failure. Eur J Heart Fail 5: 725-732, 2003.
43. Ono Y, Ito H, Tamamori M, Nozato T, Adachi S, Abe S, Marumo F, and Hiroe M. Role and relation of p70 S6 and extracellular signal-regulated kinases in the phenotypic changes of hypertrophy of cardiac myocytes. Jpn Circ J 64: 695-700, 2000.
44. Paolisso G, Galzerano D, Gambardella A, Varricchio G, Saccomanno F, D'Amore A, Varricchio M, and D'Onofrio F. Left ventricular hypertrophy is associated with a stronger impairment of non-oxidative glucose metabolism in hypertensive patients. Eur J Clin Invest 25: 529-533, 1995.
45. Prisant LM and Carr AA. Ambulatory blood pressure monitoring and echocardiographic left ventricular wall thickness and mass. Am J Hypertens 3: 81-89, 1990.
46. Rhodes CJ and White MF. Molecular insights into insulin action and secretion. Eur J Clin Invest 32, Suppl 3: 3-13, 2002.
47. Sadoshima J and Izumo S. Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy. Circ Res 77: 1040-1052, 1995.
48. Sahn DJ, DeMaria A, Kisslo J, and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072-1083, 1978.
49. Shah OJ, Kimball SR, and Jefferson LS. Among translational effectors, p70S6k is uniquely sensitive to inhibition by glucocorticoids. Biochem J 347: 389-397, 2000.
50. Sharp SD and Williams RR. Fasting insulin and left ventricular mass in hypertensives and normotensive controls. Cardiology 81: 207-212, 1992.
51. Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, Lawitts J, Cantley LC, and Izumo S. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19: 2537-2548, 2000.
52. Simm A, Schluter K, Diez C, Piper HM, and Hoppe J. Activation of p70(S6) kinase by beta-adrenoceptor agonists on adult cardiomyocytes. J Mol Cell Cardiol 30: 2059-2067, 1998.
53. Stolba P, Husek P, and Kunes J. Blood pressure changes induced by chronic insulin treatment in Wistar rats. Physiol Res 43: 329-334, 1994.
54. Sundstrom J, Lind L, Nystrom N, Zethelius B, Andren B, Hales CN, and Lithell HO. Left ventricular concentric remodeling rather than left ventricular hypertrophy is related to the insulin resistance syndrome in elderly men. Circulation 101: 2595-2600, 2000.
55. Taniyama Y, Ushio-Fukai M, Hitomi H, Rocic P, Kingsley MJ, Pfahnl C, Weber DS, Alexander RW, and Griendling KK. Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells. Am J Physiol Cell Physiol 287: C494-C499, 2004.
56. Townsend RR. Angiotensin and insulin resistance: conspiracy theory. Curr Hypertens Rep 5: 110-116, 2003.
57. Tremblay F and Marette A. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J Biol Chem 276: 38052-38060, 2001.
58. Ueki K, Fruman DA, Yballe CM, Fasshauer M, Klein J, Asano T, Cantley LC, and Kahn CR. Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling. J Biol Chem 278: 48453-48466, 2003.
59. Unger T. Neurohormonal modulation in cardiovascular disease. Am Heart J 139: S2-S8, 2000.
60. Velloso LA, Folli F, Sun XJ, White MF, Saad MJ, and Kahn CR. Cross-talk between the insulin and angiotensin signaling systems. Proc Natl Acad Sci USA 93: 12490-12495, 1996.
61. Verhaeghe J, Suiker AM, VisSerWJ, Van Herck E, Van Bree R, and Bouillon R. The effects of systemic insulin, insulin-like growth factor-I and growth hormone on bone growth and turnover in spontaneously diabetic BB rats. J Endocrinol 134: 485-492, 1992.
62. White MF and Kahn CR. The insulin signaling system. J Biol Chem 269: 1-4, 1994.
63. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Mizuno T, Takano H, Hiroi Y, Ueki K, Tobe K, Kadowaki T, Nagai R, and Yazaki Y. Mechanical stress activates protein kinase cascade of phosphorylation in neonatal rat cardiac myocytes. J Clin Invest 96: 438-446, 1995.